RWJ-51204

From WikiMD.org
Jump to navigation Jump to search

RWJ-51204

RWJ-51204 (pronunciation: /ɑːr dʌbəljuː dʒeɪ faɪf wʌn tuː oʊ fɔːr/) is a pharmacological compound that is classified under the category of anxiolytic drugs. It is known for its potential in treating anxiety disorders and related conditions.

Etymology

The term "RWJ-51204" is a systematic name given by the pharmaceutical company Johnson & Johnson, where "RWJ" stands for Robert Wood Johnson, the founder of the company. The numbers "51204" are arbitrary and do not carry any specific meaning.

Pharmacology

RWJ-51204 is a non-benzodiazepine anxiolytic that acts as a partial agonist at GABAA receptors. It is believed to have a similar mechanism of action to other non-benzodiazepine anxiolytics, such as buspirone and gepirone, but with a different chemical structure.

Clinical Use

RWJ-51204 has been studied for its potential use in the treatment of Generalized Anxiety Disorder (GAD) and other related anxiety disorders. However, as of now, it is not approved for any medical use by any health authority.

Related Terms

  • Anxiolytic: A class of medication used to treat anxiety and related disorders.
  • GABAA receptors: A type of protein within the body that RWJ-51204 interacts with to produce its effects.
  • Buspirone: A non-benzodiazepine anxiolytic with a similar mechanism of action to RWJ-51204.
  • Gepirone: Another non-benzodiazepine anxiolytic with a similar mechanism of action to RWJ-51204.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski